Vitamin B9 Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Sales Channel (Direct, Indirect), By End Use (Pharmaceutical, Food, Animal Feed,Cosmetic & Personal Care, Others), By Region and Competition, 2020-2030F

Description

The Global Vitamin B9 Market was valued at USD 87.10 Million in 2024 and is projected to reach USD 106.91 Million by 2030, growing at a CAGR of 2.45%. Vitamin B9, also known as folate or folic acid, is essential for DNA synthesis, red blood cell production, and fetal development, making it a critical nutrient across various life stages, particularly during pregnancy. Rising focus on preventive healthcare and increased consumer awareness about nutritional deficiencies are driving demand for Vitamin B9 supplements, especially in North America and Europe. Government initiatives aimed at reducing anemia and neural tube defects in newborns have further encouraged folic acid fortification and supplementation. However, the market faces obstacles such as regulatory complexities, raw material price fluctuations, and the potential side effects of excessive intake. Despite these challenges, ongoing R&D investments, strategic partnerships, and expansion into underpenetrated regions are expected to shape the market's growth trajectory.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 87.10 Million
Market Size 2030	USD 106.91 Million
CAGR 2025-2030	2.45%
Fastest Growing Segment	Direct
Largest Market	North America

Key Market Drivers

Growth in Pharmaceutical Industry

The expanding pharmaceutical industry serves as a key driver for the Vitamin B9 market, fueled by the sector's focus on disease prevention, prenatal health, and nutritional therapies. By 2023, the pharmaceutical market had reached revenues of approximately USD 1.6 trillion, highlighting its global scale and influence. Vitamin B9 is indispensable in therapeutic applications due to its roles in cell division, DNA synthesis, and hematopoiesis. It is extensively used in prenatal supplements to prevent neural tube defects and is increasingly incorporated into treatments for anemia, cognitive decline, and cardiovascular health. The market has seen innovations like Manna iStrong, a fortified drink launched by Southern Health Foods Pvt Ltd. in India, which delivers 100% of the RDA for Vitamin B9 among others. In regions where fortified foods are less accessible, pharmaceutical-grade supplements are vital, particularly in maternal and elderly care segments.

Key Market Challenges

Raw Material Supply Disruptions

Raw material supply instability presents a significant hurdle for Vitamin B9 manufacturers. The market is highly dependent on specific chemical intermediates and ingredients, predominantly sourced from a few global suppliers. Events such as geopolitical tensions, trade regulations, and natural disasters, as well as pandemics like COVID-19, have exposed vulnerabilities in the global supply chain. Countries such as China and India play critical roles in supplying active pharmaceutical ingredients (APIs) and intermediates, meaning regulatory changes or environmental policy shifts in these regions can disrupt production. These constraints not only elevate costs but also introduce delays and uncertainty for manufacturers, particularly small and medium-sized enterprises.

Key Market Trends

Increasing Demand for Dietary Supplements

The growing global emphasis on preventive healthcare is fueling demand for dietary supplements, making it a defining trend in the Vitamin B9 market. Consumers are increasingly turning to supplements to support immune function, address nutritional gaps, and reduce disease risk. Folic acid's inclusion in multivitamins and prenatal products is becoming more common due to its crucial role in cellular health, red blood cell formation, and fetal development. Products like Merck's Arcofolin L-Methylfolate represent a new generation of folate supplements designed for enhanced bioavailability and metabolic efficiency. This trend is particularly pronounced in North America, Europe, and emerging markets in Asia-Pacific, where health-conscious lifestyles and increased awareness are driving consistent growth in the consumption of Vitamin B9-enriched supplements.

Key Market Players

Anhui Xinhong Chemical Co., Ltd
Changzhou Niutang Chemical Plant Co., Ltd.
Zhejiang Shengda Bio-Pharm Co., Ltd.
Xinfa Pharmaceutical Co., Ltd.
Jiangxi Tianxin Pharmaceutical Co., Ltd.
Hebei Jiheng (Group) Pharmaceutical Co., Ltd.

Report Scope

In this report, the Global Vitamin B9 Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Vitamin B9 Market, By Sales Channel:

Direct
Indirect

Vitamin B9 Market, By End Use:

Pharmaceutical
Food
Animal Feed
Cosmetic & Personal Care
Others

Vitamin B9 Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Vitamin B9 Market.

Available Customizations

Global Vitamin B9 Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends

4. Impact of COVID-19 on Global Vitamin B9 Market

5. Global Vitamin B9 Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Sales Channel (Direct, Indirect)
- 5.2.2. By End Use (Pharmaceutical, Food, Animal Feed ,Cosmetic & Personal Care, Others)
- 5.2.3. By Region
- 5.2.4. By Company (2024)
5.3. Market Map

6. North America Vitamin B9 Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Sales Channel
- 6.2.2. By End Use
- 6.2.3. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Vitamin B9 Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Sales Channel
    - 6.3.1.2.2. By End Use
- 6.3.2. Mexico Vitamin B9 Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Sales Channel
    - 6.3.2.2.2. By End Use
- 6.3.3. Canada Vitamin B9 Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Sales Channel
    - 6.3.3.2.2. By End Use

7. Europe Vitamin B9 Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Sales Channel
- 7.2.2. By End Use
- 7.2.3. By Country
7.3. Europe: Country Analysis
- 7.3.1. France Vitamin B9 Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Sales Channel
    - 7.3.1.2.2. By End Use
- 7.3.2. Germany Vitamin B9 Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Sales Channel
    - 7.3.2.2.2. By End Use
- 7.3.3. United Kingdom Vitamin B9 Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Sales Channel
    - 7.3.3.2.2. By End Use
- 7.3.4. Italy Vitamin B9 Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Sales Channel
    - 7.3.4.2.2. By End Use
- 7.3.5. Spain Vitamin B9 Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Sales Channel
    - 7.3.5.2.2. By End Use

8. Asia Pacific Vitamin B9 Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Sales Channel
- 8.2.2. By End Use
- 8.2.3. By Country
8.3. Asia Pacific: Country Analysis
- 8.3.1. China Vitamin B9 Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Sales Channel
    - 8.3.1.2.2. By End Use
- 8.3.2. India Vitamin B9 Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Sales Channel
    - 8.3.2.2.2. By End Use
- 8.3.3. South Korea Vitamin B9 Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Sales Channel
    - 8.3.3.2.2. By End Use
- 8.3.4. Japan Vitamin B9 Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Sales Channel
    - 8.3.4.2.2. By End Use
- 8.3.5. Australia Vitamin B9 Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Sales Channel
    - 8.3.5.2.2. By End Use

9. South America Vitamin B9 Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Sales Channel
- 9.2.2. By End Use
- 9.2.3. By Country
9.3. South America: Country Analysis
- 9.3.1. Brazil Vitamin B9 Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Sales Channel
    - 9.3.1.2.2. By End Use
- 9.3.2. Argentina Vitamin B9 Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Sales Channel
    - 9.3.2.2.2. By End Use
- 9.3.3. Colombia Vitamin B9 Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Sales Channel
    - 9.3.3.2.2. By End Use

10. Middle East and Africa Vitamin B9 Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Sales Channel
- 10.2.2. By End Use
- 10.2.3. By Country
10.3. MEA: Country Analysis
- 10.3.1. South Africa Vitamin B9 Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Sales Channel
    - 10.3.1.2.2. By End Use
- 10.3.2. Saudi Arabia Vitamin B9 Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Sales Channel
    - 10.3.2.2.2. By End Use
- 10.3.3. UAE Vitamin B9 Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Sales Channel
    - 10.3.3.2.2. By End Use

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Global Vitamin B9 Market: SWOT Analysis

14. Porters Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Anhui Xinhong Chemical Co., Ltd
- 15.1.1. Business Overview
- 15.1.2. Company Snapshot
- 15.1.3. Products & Services
- 15.1.4. Financials (As Reported)
- 15.1.5. Recent Developments
- 15.1.6. Key Personnel Details
- 15.1.7. SWOT Analysis
15.2. Changzhou Niutang Chemical Plant Co., Ltd.
15.3. Zhejiang Shengda Bio-Pharm Co., Ltd.
15.4. Xinfa Pharmaceutical Co., Ltd.
15.5. Jiangxi Tianxin Pharmaceutical Co., Ltd.
15.6. Hebei Jiheng (Group) Pharmaceutical Co., Ltd.